SE7601125L - PROCEDURE FOR THE PREPARATION OF A CYTOTOXIC AGENT - Google Patents

PROCEDURE FOR THE PREPARATION OF A CYTOTOXIC AGENT

Info

Publication number
SE7601125L
SE7601125L SE7601125A SE7601125A SE7601125L SE 7601125 L SE7601125 L SE 7601125L SE 7601125 A SE7601125 A SE 7601125A SE 7601125 A SE7601125 A SE 7601125A SE 7601125 L SE7601125 L SE 7601125L
Authority
SE
Sweden
Prior art keywords
procedure
preparation
cytotoxic agent
cytotoxic
agent
Prior art date
Application number
SE7601125A
Other languages
Unknown language ( )
Swedish (sv)
Inventor
G F Rowland
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB4695/75A external-priority patent/GB1496011A/en
Application filed by Searle & Co filed Critical Searle & Co
Publication of SE7601125L publication Critical patent/SE7601125L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44Antibodies bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
SE7601125A 1975-02-04 1976-02-03 PROCEDURE FOR THE PREPARATION OF A CYTOTOXIC AGENT SE7601125L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4695/75A GB1496011A (en) 1974-11-22 1975-02-04 Defoaming composition

Publications (1)

Publication Number Publication Date
SE7601125L true SE7601125L (en) 1976-08-05

Family

ID=9782062

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7601125A SE7601125L (en) 1975-02-04 1976-02-03 PROCEDURE FOR THE PREPARATION OF A CYTOTOXIC AGENT

Country Status (5)

Country Link
JP (1) JPS51126281A (en)
BE (1) BE838273A (en)
DK (1) DK43676A (en)
NL (1) NL7601132A (en)
SE (1) SE7601125L (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57143326A (en) * 1981-03-03 1982-09-04 Teijin Ltd Polymer linked to cellular toxic substance and its preparation
DE3205847A1 (en) * 1981-05-08 1982-12-16 Farmitalia Carlo Erba S.p.A., 20159 Milano Daunorubicin-protein conjugates
JPS60172935A (en) * 1984-02-16 1985-09-06 Green Cross Corp:The Preparation of composite material of substance having carcinostatic action
JPS611622A (en) * 1984-06-14 1986-01-07 Teijin Ltd Cytotoxic complex and preparation thereof
FR2586564B1 (en) * 1985-09-04 1989-04-07 Pierre Tran Ba Loc IMMUNOSUPPRESSIVE COMPOUNDS AND PROCESS FOR THEIR PREPARATION
JPS62228025A (en) * 1985-12-27 1987-10-06 Teijin Ltd Production of antibody complex
JPH0662438B1 (en) * 1986-08-28 1994-08-17 Teijin Ltd
DE3788058T2 (en) * 1986-08-28 1994-04-21 Teijin Ltd CELL TOXIC ANTIBODY COMPLEX AND METHOD FOR THE PRODUCTION THEREOF.
US5149782A (en) * 1988-08-19 1992-09-22 Tanox Biosystems, Inc. Molecular conjugates containing cell membrane-blending agents
JP2626654B2 (en) * 1990-03-31 1997-07-02 科学技術振興事業団 Targeting high molecular weight pharmaceutical compounds and intermediates thereof

Also Published As

Publication number Publication date
BE838273A (en) 1976-08-04
NL7601132A (en) 1976-08-06
DK43676A (en) 1976-08-05
JPS51126281A (en) 1976-11-04

Similar Documents

Publication Publication Date Title
SE437767B (en) PROCEDURE FOR THE PREPARATION OF AN ANTI-TUMORARY MEDICINAL PRODUCT
SE433208B (en) PROCEDURE FOR THE PREPARATION OF PHENOLETERS
SE431088B (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BENZYDRYLSULPHINYL DERIVATIVES
NO147450C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE CHINAZOLONE DERIVATIVES
SE431883B (en) PROCEDURE FOR THE PREPARATION OF A PAINTING AGENT
SE7605139L (en) PROCEDURE FOR THE PREPARATION OF WATER-INTAKING CELLULOSAETERS
SE430336B (en) IMPROVED PROCEDURE FOR THE PREPARATION OF AMOXICILLIN-FREEHYDRATE
AR217629A1 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF TIENOTETRAHIDROPIRIDINA
SE7601125L (en) PROCEDURE FOR THE PREPARATION OF A CYTOTOXIC AGENT
SE7504882L (en) PROCEDURE FOR THE PREPARATION OF A NEW PHARMACEUTICAL PREPARATION.
SE443142B (en) PROCEDURE FOR THE PREPARATION OF RIFAMYCIN COMPOUNDS
SE7606116L (en) PROCEDURE FOR THE PREPARATION OF 3-PHENOXIDE BENZALDEHIDS
SE7600910L (en) PROCEDURE FOR THE PREPARATION OF POLYURETHANES
SE7604781L (en) PROCEDURE FOR THE PREPARATION OF DIARYLHYDROXIBUTYLAMINES
SE409455B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF NITROIMIDAZOLYL-CHINAZOLINE DERIVATIVES
SE421692B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF SPIRO (CYCLOPROPANE-1,2Ÿ-INDOLINE) -3Ÿ-ON COMPOUNDS
SE414029B (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE FENTIAZINE DERIVATIVES
SE7601836L (en) PROCEDURE FOR THE PREPARATION OF A DIMERKAPTOEL TYLETER DERIVATIVE
SE404186B (en) PROCEDURE FOR THE PREPARATION OF CYCLOPROPANEL DERIVATIVES
SE7511011L (en) PROCEDURE FOR THE PREPARATION OF A SULFUR-CONTAINING PYRIDINE DERIVATIVE
SE423814B (en) PROCEDURE FOR THE PREPARATION OF DIBENSOFENAZINE OR ACENAPHTOKINOXALIN DERIVATIVES
SE421793B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NAFTYRIDINE-SUBSTITUTED PYRROLLER DERIVATIVES
SE7610637L (en) PROCEDURE FOR THE PREPARATION OF 2-ALKYLINDANES
SE446726B (en) PROCEDURE FOR THE PREPARATION OF 16-METOXIPROSTAGLANDINES
SE7605427L (en) PROCEDURE FOR THE PREPARATION OF CHLORCYANE

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7601125-3